The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer
DC McMillan - Cancer treatment reviews, 2013 - Elsevier
Since the initial work, a decade ago that the combination of C-reactive protein and albumin,
the Glasgow Prognostic Score (GPS), had independent prognostic value in patients with …
the Glasgow Prognostic Score (GPS), had independent prognostic value in patients with …
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma
The pathogenesis of hepatocellular carcinoma (HCC) strongly relates to inflammation, with
chronic up‐regulation of pro‐inflammatory mediators standing as a potential unifying …
chronic up‐regulation of pro‐inflammatory mediators standing as a potential unifying …
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with …
T Tada, T Kumada, A Hiraoka, K Kariyama… - Cancer …, 2023 - Wiley Online Library
Abstract Aim Recently, the neo‐Glasgow prognostic score (GPS), a composite biomarker
determined by the C‐reactive protein level and albumin–bilirubin grade, was developed to …
determined by the C‐reactive protein level and albumin–bilirubin grade, was developed to …
[HTML][HTML] The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
A Kinoshita, H Onoda, N Imai, A Iwaku, M Oishi… - BMC cancer, 2013 - Springer
Abstract Background Elevated Glasgow Prognostic Score (GPS) has been related to poor
prognosis in patients with hepatocellular carcinoma (HCC) undergoing surgical resection or …
prognosis in patients with hepatocellular carcinoma (HCC) undergoing surgical resection or …
[HTML][HTML] Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma
JS Chu, FJ Ge, B Zhang, Y Wang, N Silvestris… - Journal of Experimental …, 2013 - Springer
Background We explore the clinical and prognostic significance of expression of vascular
endothelial growth factor receptor (VEGFR)-2, platelet-derived growth factor receptor …
endothelial growth factor receptor (VEGFR)-2, platelet-derived growth factor receptor …
[HTML][HTML] Prognostic role of glasgow prognostic score in patients with hepatocellular carcinoma: a systematic review and meta-analysis
M Li, X Bi, Z Li, Z Huang, Y Han, J Zhou, J Zhao… - Medicine, 2015 - journals.lww.com
Conflicting results about the prognostic value of Glasgow Prognostic Score (GPS) in
hepatocellular carcinoma (HCC) patients have been reported. We searched the available …
hepatocellular carcinoma (HCC) patients have been reported. We searched the available …
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
T Terashima, T Yamashita, N Iida… - Hepatology …, 2015 - Wiley Online Library
Aim Inflammation plays a critical role in cancer. The aim of the present study was to
investigate the impact of neutrophil to lymphocyte ratio (NLR) on patients with advanced …
investigate the impact of neutrophil to lymphocyte ratio (NLR) on patients with advanced …
[HTML][HTML] Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib
Results 442 patients with advanced stage HCC on sorafenib were recruited (follow-up 5096
person-months at risk). 88% had BCLC stage B or greater HCC and 72.3% had Child-Pugh …
person-months at risk). 88% had BCLC stage B or greater HCC and 72.3% had Child-Pugh …
Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide
E Topkan, U Selek, Y Ozdemir, BA Yildirim… - Journal of Neuro …, 2018 - Springer
Introduction To evaluate the prognostic value of the Glasgow Prognostic Score (GPS), the
combination of C-reactive protein (CRP) and albumin, in glioblastoma multiforme (GBM) …
combination of C-reactive protein (CRP) and albumin, in glioblastoma multiforme (GBM) …
[HTML][HTML] Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma
M Shomura, T Kagawa, K Shiraishi… - World Journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To study the relationship between adverse events (AEs), efficacy, and nursing
intervention for sorafenib therapy in patients with hepatocellular carcinoma (HCC) …
intervention for sorafenib therapy in patients with hepatocellular carcinoma (HCC) …